Maywufa Company Ltd. (1731.TW)
TWD 21.8
(0.0%)
TWD 21.8
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 854.37 Million TWD | 4.63% |
| 2022 | 816.55 Million TWD | -4.99% |
| 2021 | 859.44 Million TWD | 27.09% |
| 2020 | 676.27 Million TWD | 0.95% |
| 2019 | 669.88 Million TWD | 3.96% |
| 2018 | 644.36 Million TWD | -4.83% |
| 2017 | 677.09 Million TWD | 9.18% |
| 2016 | 620.17 Million TWD | -1.64% |
| 2015 | 630.54 Million TWD | 11.85% |
| 2014 | 563.71 Million TWD | 6.4% |
| 2013 | 529.81 Million TWD | -4.05% |
| 2012 | 552.15 Million TWD | -0.69% |
| 2011 | 555.98 Million TWD | -13.8% |
| 2010 | 644.99 Million TWD | 1.1% |
| 2009 | 638 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 221.8 Million TWD | -17.81% |
| 2024 Q1 | 269.85 Million TWD | 20.07% |
| 2023 Q2 | 207.95 Million TWD | -8.11% |
| 2023 Q1 | 226.31 Million TWD | 13.41% |
| 2023 Q4 | 224.74 Million TWD | 15.04% |
| 2023 Q3 | 195.35 Million TWD | -6.06% |
| 2023 FY | 854.37 Million TWD | 4.63% |
| 2022 Q1 | 224.71 Million TWD | 1.8% |
| 2022 Q3 | 200.34 Million TWD | 4.37% |
| 2022 FY | 816.55 Million TWD | -4.99% |
| 2022 Q4 | 199.54 Million TWD | -0.4% |
| 2022 Q2 | 191.95 Million TWD | -14.58% |
| 2021 FY | 859.44 Million TWD | 27.09% |
| 2021 Q1 | 200.32 Million TWD | 20.6% |
| 2021 Q2 | 207.42 Million TWD | 3.54% |
| 2021 Q3 | 230.94 Million TWD | 11.34% |
| 2021 Q4 | 220.75 Million TWD | -4.41% |
| 2020 FY | 676.27 Million TWD | 0.95% |
| 2020 Q2 | 152.3 Million TWD | -9.87% |
| 2020 Q1 | 168.99 Million TWD | 9.66% |
| 2020 Q3 | 188.86 Million TWD | 24.01% |
| 2020 Q4 | 166.1 Million TWD | -12.05% |
| 2019 Q1 | 191.47 Million TWD | 29.65% |
| 2019 Q3 | 157.93 Million TWD | -5.06% |
| 2019 Q4 | 154.1 Million TWD | -2.42% |
| 2019 FY | 669.88 Million TWD | 3.96% |
| 2019 Q2 | 166.36 Million TWD | -13.11% |
| 2018 FY | 644.36 Million TWD | -4.83% |
| 2018 Q2 | 159.09 Million TWD | -9.7% |
| 2018 Q1 | 176.18 Million TWD | 6.35% |
| 2018 Q4 | 147.68 Million TWD | -8.5% |
| 2018 Q3 | 161.4 Million TWD | 1.45% |
| 2017 Q2 | 169.26 Million TWD | 1.14% |
| 2017 Q3 | 174.79 Million TWD | 3.27% |
| 2017 FY | 677.09 Million TWD | 9.18% |
| 2017 Q1 | 167.36 Million TWD | 5.07% |
| 2017 Q4 | 165.65 Million TWD | -5.23% |
| 2016 Q3 | 156.26 Million TWD | 5.68% |
| 2016 FY | 620.17 Million TWD | -1.64% |
| 2016 Q4 | 159.29 Million TWD | 1.94% |
| 2016 Q2 | 147.86 Million TWD | -5.67% |
| 2016 Q1 | 156.75 Million TWD | -2.35% |
| 2015 Q2 | 148.24 Million TWD | -11.75% |
| 2015 Q1 | 167.98 Million TWD | 11.88% |
| 2015 FY | 630.54 Million TWD | 11.85% |
| 2015 Q4 | 160.52 Million TWD | 4.38% |
| 2015 Q3 | 153.78 Million TWD | 3.74% |
| 2014 Q3 | 145.29 Million TWD | 11.01% |
| 2014 Q2 | 130.87 Million TWD | -4.74% |
| 2014 FY | 563.71 Million TWD | 6.4% |
| 2014 Q1 | 137.39 Million TWD | 5.43% |
| 2014 Q4 | 150.14 Million TWD | 3.34% |
| 2013 Q4 | 130.31 Million TWD | 6.27% |
| 2013 Q2 | 130.33 Million TWD | -11.0% |
| 2013 Q3 | 122.62 Million TWD | -5.91% |
| 2013 FY | 529.81 Million TWD | -4.05% |
| 2013 Q1 | 146.43 Million TWD | 7.33% |
| 2012 Q4 | 136.42 Million TWD | 0.84% |
| 2012 Q1 | 145.92 Million TWD | 8.49% |
| 2012 Q2 | 134.06 Million TWD | -8.13% |
| 2012 Q3 | 135.29 Million TWD | 0.92% |
| 2012 FY | 552.15 Million TWD | -0.69% |
| 2011 FY | 555.98 Million TWD | -13.8% |
| 2011 Q3 | 130.58 Million TWD | 4.34% |
| 2011 Q2 | 125.15 Million TWD | -24.48% |
| 2011 Q1 | 165.73 Million TWD | 0.19% |
| 2011 Q4 | 134.5 Million TWD | 3.0% |
| 2010 Q3 | 154.91 Million TWD | -2.96% |
| 2010 Q2 | 159.63 Million TWD | -3.26% |
| 2010 FY | 644.99 Million TWD | 1.1% |
| 2010 Q1 | 165.01 Million TWD | 0.0% |
| 2010 Q4 | 165.42 Million TWD | 6.78% |
| 2009 FY | 638 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Grape King Bio Ltd | 8.53 Billion TWD | 89.988% |
| Standard Chem & Pharm CO., LTD. | 2.72 Billion TWD | 68.651% |
| ScinoPharm Taiwan, Ltd. | 1.21 Billion TWD | 29.739% |
| Lotus Pharmaceutical Co., Ltd. | 8.33 Billion TWD | 89.755% |
| LIWANLI Innovation Co., Ltd. | 15.08 Million TWD | -5564.47% |
| YungShin Global Holding Corporation | 2.91 Billion TWD | 70.651% |
| PhytoHealth Corporation | 67.64 Million TWD | -1163.06% |
| SCI Pharmtech, Inc. | 350.32 Million TWD | -143.881% |
| Formosa Laboratories, Inc. | 1.9 Billion TWD | 55.11% |
| PharmaEssentia Corporation | 4.49 Billion TWD | 80.993% |
| Bora Pharmaceuticals Co., LTD. | 6.99 Billion TWD | 87.779% |